Boyds expands Regulatory Affairs team to support growing demand
Consultancy, Diagnostics, Pharmacy, drug development, life sciences, regulatory affairs
Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs. Hayes …
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing
Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026Devices, Diagnostics, Hospital Management, Oncology, laser imaging, lung disease, tumour
Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026Diagnostics, Haematology, Neurological Diseases, Neurology, Parkinson's disease, blood testing, sleep disorder
Researchers at King Abdullah University of Science and Technology (KAUST) and the University of Oxford have developed a blood-based electronic …
Cori Clinical raises US$4m to expand AI platform for clinical trial design
October 14, 2026AI, Data Capture, Pharmacy, clinical data, clinical trial design, regulatory affairs
Cori Clinical has raised US$4m in a seed funding round to expand its AI platform for clinical trial design and …
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026Biotechnology, CDMO, Pharmacy, acquisitions, drug substance development
Ofichem has agreed to acquire Kinentia Biosciences, a US drug substance contract development and manufacturing organisation (CDMO), in a deal …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026FDA, Female Sexual Disorders, Genito-Urinary system, HRT, Obstetrics & Gynaecology, specialty pharmaceuticals, women's health
Netherlands-based clinical-stage biopharmaceutical company developing innovative therapies for women with Female Sexual Disorders (FSD), Arletta Pharma Solutions has appointed Jeannette …
Tridem begins phase Ib trial of Parkinson’s disease vaccine
October 13, 2026Cardiology, Neurology, Parkinson's disease, Vaccine, clinical trial
Tridem Bioscience has enrolled the first patients in a phase Ib clinical trial of TRB-001, an intradermal therapeutic vaccine targeting …
Bio-Techne opens GMP small-molecule manufacturing facility in Bristol
October 13, 2026Cardiology, Cleanroom, Diabetes, Haematology, Neurology, Rare Diseases, cell therapies, manufacturing and production, small molecules
Bio-Techne has opened a new facility in Bristol manufacturing Good Manufacturing Practice (GMP)-grade small molecules for cell therapy developers. The …
Trio become latest Symbiosis commercial additions
October 12, 2026CDMO, Devices, Diagnostics, Immunology, clinical trials, pharmaceutical markets
Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and JoaquÃn Pérez Fornieles join …
UK immunoglobulin supply faces growing pressure, report warns
October 12, 2026Manufacturing and Production Critical supplies, Immunology, NHS Blood and Transplant, Neurology, procurement
The UK may face increasing pressure to secure long-term supplies of immunoglobulin (Ig), with rising demand and heavy reliance on …
How will biomarker-led diagnostics reshape respiratory medicine?
October 11, 2026Asthma & COPD, COPD, Chronic Diseases, Diagnostics, biomarkers, clinical trial
By Dr Louise Ryan Murphy, Chronic obstructive pulmonary disease (COPD) is typically diagnosed and assessed through symptoms, lung function and …
Five Facts about COPD
October 11, 2026Medical Communications Asthma & COPD, COPD, Five Facts, HRT, Smoking Cessation, chronic bronchitis, emphysema, smoking
1 Chronic obstructive pulmonary disease is a group of progressive lung conditions, principally emphysema and chronic bronchitis, that restrict airflow …
“That gap between innovation and delivery was what stood out to me most”
October 11, 2026Drug Delivery Systems, Drug Safety, Marketing, Medical Communications, Regulatory Affairs AI governance, Asthma & COPD, Chronic Diseases, Devices, Diagnostics, Hospital Management, NHS, drug delivery, healthcare solutions, pharmaceutical technology
Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and putting the patient at the …
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
October 11, 2026Licenses/Quality Standards, Marketing, Sales & Marketing Training AI, Devices, Diagnostics, Hospital Management, Pharmacy, biopharma, medical adoption, pharmaceutical
By Chris Moore Commercial engagement in biopharma used to centre largely on direct conversations between sales reps and physicians or …
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study
October 11, 2026Chronic Diseases, NHS, Oncology, cardiovascular disease, survey
People in their forties account for almost three-quarters of those who do not attend NHS Health Checks, highlighting the challenge …
Excellence in Healthcare Partnership Awards – A Collaborative Working Project Between Sanofi and The University Hospital Birmingham Severe Asthma Team
October 11, 2026Data Management, Medical Communications, Medical Education, Patient Awareness Programmes, Quality Assurance, Training Asthma & COPD, Chronic Diseases, EHP Awards, HCPs, Sanofi
Launched in February 2026 by PMGroup Worldwide Ltd and Visions4Health, the Excellence in Healthcare Partnerships (EHP) Awards recognise outstanding collaborations …
NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma
October 8, 2026NICE, Oncology, drug recommendation, drug regulation
NICE has published final draft guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone (D-VRd) for previously untreated adults with multiple …
AstraZeneca’s Trixeo approved in EU for asthma
October 8, 2026Asthma & COPD, AstraZeneca, EU
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved in the European Union as a maintenance treatment for asthma in …
Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis
October 7, 2026Rheumatology, clinical testing, immunology, rheumatoid arthritis
Amplio Pharma has reported phase 1b results for NovoBioJect, an investigational combination of low-dose methotrexate (MTX) and novobiocin being developed …
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
October 6, 2026Diabetes, GLP-1, Obesity, diabetes, obesity, phase 3 trial
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in people with obesity or overweight …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
